Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Monday December 07, 2015 | ENZO Biochem Reports Strong First Quarter Results Execution on Corporate Strategy seen in Company’s Results |
Friday December 04, 2015 | ENZO Biochem Schedules Teleconference to Discuss First Quarter 2016 Results Tuesday, December 8, 2015 at 8:30 Am E.T. |
Wednesday November 25, 2015 | ENZO Biochem Releases New Investor Presentation on Corporate Strategy |
Tuesday November 17, 2015 | Enzo Biochem Announces New York State Approval of Its First Assay Based on Ampiprobe™ Platform Aimed at Providing Affordable Molecular Diagnostics in Light of Reimbursement Pressure |
Thursday October 29, 2015 | ENZO Biochem Demonstrates Greater Sensitivity of Its Ampiprobe™ Platform for Molecular Diagnostics |
Tuesday October 13, 2015 | ENZO Biochem Reports Strong Fourth Quarter Results |
Tuesday October 13, 2015 | ENZO Biochem Reaches $10 Million Patent Infringement Settlement with Affymetrix, Inc. |
Wednesday October 07, 2015 | ENZO Biochem Schedules Teleconference To Discuss Fourth Quarter and Full Year Results Tuesday, October 13, 2015 At 8:30 Am E.T. |
Wednesday July 22, 2015 | ENZO Biochem Reaches Patent Infringement Settlement - PRESS RELEASE |
Wednesday July 22, 2015 | ENZO Biochem Reaches Patent Infringement Settlement - FORM 8K |
Wednesday July 08, 2015 | Enzo Biochem Reports Favorable Delaware Court Markman Hearing Ruling |
Monday July 06, 2015 | Enzo Biochem to Present at Cantor Fitzgerald Healthcare Conference |
Monday July 06, 2015 | Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex Corporation |
Tuesday June 09, 2015 | ENZO Biochem Reports Third Quarter Results, Including Strong Revenue Growth at Clinical Labs Reflecting Increasing Volume and Greater Molecular Diagnostic Activity |
Thursday June 04, 2015 | ENZO Biochem Schedules Teleconference to Discuss Third Quarter Results Wednesday, June 10, 2015 At 8:30 Am E.T. |
Monday March 16, 2015 | ENZO Biochem to Request Rehearing of Court of Appeals Decision |
Friday, March 13, 2015 | ENZO Biochem Announces New York State Approval of First Flowscript™ Assay For Improved Detection of Cervical Cancer Progression |
Thursday March 12, 2015 | ENZO Biochem Reports Fiscal Second Quarter Results March 12, 2015 |
Monday March 9, 2015 | ENZO Biochem Schedules Teleconference to Discuss Second Quarter Results Friday, March 13, 2015 at 8:30 Am E.T. |
Tuesday, February 10, 2015 | Enzo Biochem Announces New Molecular Platform and First Product for Early Focus on Cervical Cancer Progression |